Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing fenebrutinib with teriflunomide in relapsing multiple sclerosis is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing Multiple Sclerosis

Drugs mentioned

• Fenebrutinib (Fenebrutinib)
• Teriflunomide (teriflunomide)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Relapsing Multiple Sclerosis | Phase 3 | Status: ACTIVE_NOT_RECRUITING